Prostate News Archive
18-Oct-2006
Prostate test that is 90% accurate (Daily Mail)
A new genetic test that is more than 90 per cent accurate should end 'agonising uncertainty' for thousands of men with signs of prostate cancer - and make a national screening programme for the disease a real possibility for the first time New prostate cancer therapy is studied (UPI)
IOWA CITY, Iowa, Oct. 16 (UPI) -- A team of U.S. researchers is starting a clinical trial of a novel therapeutic that might lead to new treatments for men diagnosed with prostate cancer. University of Iowa researchers initiate prostate cancer study (Pharmaceutical Business Review)
University of Iowa Health Care researchers have launched a clinical trial of a new therapeutic that may eventually lead to new treatments for men diagnosed with prostate cancer. Research calls for more awareness of prostate cancer (Australian Broadcasting Corporation)
MARK COLVIN: Each year, just as many men die from prostate cancer as women do from breast cancer. But while the breast cancer campaign has been a huge success, men are much less likely to have their prostates tested. Researchers Publish Largest Genome-wide Study Of Prostate Cancer In African American Men (Science Daily)
Researchers from 14 institutions across the country recently announced the results of the first genome-wide linkage study of prostate cancer in African Americans. Using genetic markers, researchers identified several regions of the human genome that likely contain genes that, when altered, increase the risk of developing prostate cancer. Kenya: More Men Fall Victim to Prostate Cancer (AllAfrica.com)
Kenyan men are increasingly falling victim to a silent killer - prostate cancer. Research by the Nairobi Cancer Registry indicates that up to 8.1 per cent of Kenyan men over the age of 40 could be affected. The percentage increases as men go into their 60s and 70s. Researchers Studying Novel Therapy For Prostate Cancer (Science Daily)
A team of University of Iowa Health Care researchers has launched an important clinical trial of a novel therapeutic that may eventually lead to new treatments for men diagnosed with prostate cancer. Chicago Prostate Cancer Center First in World to Reach 100 Patient Implants Using Cesium-131(TM), Isotope From IsoRay (Business Wire via Yahoo! Finance)
CHICAGO----Chicago prostate Cancer Center reached a major milestone in prostate brachytherapy October 4, 2006, becoming the world's first cancer center to treat 100 patients using Cesium-131, a powerful new medical isotope developed and manufactured by IsoRay Medical, Inc.
Back to Prostate News Archive
